Schwid SR, Covington M, Segal BM, Goodman AD. Fatigue in multiple sclerosis: current understanding and future directions. J Rehabil Res Dev. 2002;39:211–24.
Krupp L, Alvarez L, LaRocca NG, Scheinberg L. Fatigue in multiple sclerosis. Arch Neurol. 1988;45:435–7.
Freal JE, Draft GH, Coryell J. Symptomatic faigue in multiple sclerosis. Arch Phys Med Rehabil. 1984;65:135–8.
Mead G, Lynch J, Greig C, et al. Evaluation of fatigue scales in stroke patients. Stroke. 2007;38:2090–5.
Staub F, Bogousslavsky J. Fatigue after stroke: a major but neglected issue. Cerebrovasc Dis Basel Switz. 2001;12:75–81.
Krupp LB, LaRocca NG, Muir-Nash J, Steinberg AD. The Fatigue Severity Scale: application to patients with multiple sclerosis and systemic lupus erythematosus. Arch Neurol. 1989;46:1121–3.
Fisk JD, Ritvo PC, Ross L, Haase DA, Marrie TJ, Schlech WF. Measuring the functional impact of fatigue: initial validation of the Fatigue Impact Scale. Clin Infect Dis. 1994;18:S79–83.
Amtmann D, Bamer AM, Noonan V, Lang N, Kim J, Cook KF. Comparison of the psychometric properties of two fatigue scales in multiple sclerosis. Rehabil Psychol. 2012;57:159–66.
Mills RJ, Young CA, Pallant JF, Tennant A. Development of a patient reported outcome scale for fatigue in multiple sclerosis: the Neurological Fatigue Index (NFI-MS). Health Qual Life Outcomes. 2010;8:22.
Johansson B, Starmark A, Berglund P, Rodholm M, Ronnback L. A self-assessment questionnaire for mental fatigue and related symptoms after neurological disorders and injuries. Brain Inj. 2010;24:2–12.
Michielsen HJ, De Vries J, Van Heck GL. Psychometric qualities of a brief self-rated fatigue measure: the Fatigue Assessment Scale. J Psychosom Res. 2003;54:345–52.
Smets EM, Garssen B, Bonke B, et al. The multidimensional fatigue inventory (MFI) psychometric qualities of an instrument to assess fatigue. J Psychosom Res. 1995;39:315–25.
Penner IK, Raselli C, Stöcklin M, Opwis K, Kappos L, Calabrese P. The fatigue scale for motor and cognitive functions (FSMC): validation of a new instrument to assess multiple sclerosis-related fatigue. Mult Scler. 2009;15:1509–17.
Hubacher M, Calabrese P, Bassetti C, Carota A, Stöcklin M, Penner IK. Assessment of post-stroke fatigue: the fatigue scale for motor and cognitive functions. Eur Neurol. 2012;67:377–84.
Brassington JC, Marsh NV. Neuropsychological aspects of multiple sclerosis. Neuropsychol Rev. 1998;8:43–7.
Minden SL, Frankel D, Hadden L, Perloffp J, Srinath KP, Hoaglin DC. The Sonya Slifka Longitudinal Multiple Sclerosis Study: methods and sample characteristics. Mult Scler. 2006;12:24–38.
Opara JA, Jaracz K, Brola W. Quality of life in multiple sclerosis. J Med Life. 2010;3:352–8.
Janardhan V, Bakshi R. Quality of life in patients iwth multiple sclerosis: the impact of fatigue and depression. J Neurol Sci. 2002;205:51–8.
Smith MM, Arnett PA. Factors related to employment status changes in individuals with multiple sclerosis. Mult Scler. 2005;11:602–9.
Cadden M, Arnett PA. Factors associated with employment status in individuals with multiple sclerosis. Int J MS Care. 2015;15:284–91.
LaChapelle DL, Finlayson M. An evaluation of subjective and objective measures of fatigue in patients with brain injury and healthy controls. Brain Inj. 1998;12:649–59.
Lannsjö M, af Geijerstam JL, Johansson U, Bring J, Borg J. Prevalence and structure of symptoms at 3 months after mild traumatic brain injury in a national cohort. Brain Inj. 2009;23:213–9.
Cantor JB, Gordon W, Gumber S. What is post TBI fatigue? NeuroRehabilitation. 2013;32:875–83.
Juengst S, Skidmore E, Arenth PM, Niyonkuru C, Raina KD. The unique contribution of fatigue to disability in community dwelling adults with traumatic brain injury. Arch Phys Med Rehabil. 2013;94:74–9.
Cumming TB, Packer M, Kramer SF, et al. The prevalence of fatigue after stroke: a systematic review and meta-analysis. Int J Stroke. 2016;11:968–77.
Andersen G, Christensen D, Kirkevold M, et al. Post-stroke fatigue and return to work: a 2-year follow-up. Acta Neurol Scand. 2012;125:248–53.
Pollock A, St. George B, Fenton M, Firkins L. Top 10 research priorities relating to life after stroke—consensus from stroke survivors, caregivers, and health professionals. Int J Stroke. 2014;9:313–20.
Lou JS, Kearns G, Oken B, Sexton G, Nutt J. Exacerbated physical fatigue and mental fatigue in Parkinson’s disease. Mov Disord. 2001;16:190–6.
Nagy A, Schrag A. Neuropsychiatric aspects of Parkinson’s disease. J Neural Transm. 2019;126(7):889–96.
Lou J, Reeves A, Benice T, Sexton G. Fatigue and depression are associated with poor quality of life in ALS. Neurology. 2003;60:122–3.
Day J, Yust-Katz S, Cachia D, et al. Interventions for the management of fatigue in adults with a primary brain tumour. Cochrane Database Syst Rev. 2016;4:CD011376. https://doi.org/10.1002/14651858.CD011376.pub2.
Kluger BP, Krupp LB, Enoka RM. Fatigue and fatigability in neurologic illnesses: proposal for a unified taxonomy. Neurology. 2013;80:409–16.
Kluger BM, Herlofson K, Chou KL, et al. Parkinson’s disease-related fatigue: a case definition and recommendations for clinical research. Mov Disord. 2016;31:625–31.
Bigland-Ritchie B, Cafarelli E, Vollestad NK. Fatigue of submaximal static contractions. Acta Physiol Scand. 1986;556:137–48.
Bryant M, Chiaravalloti ND, DeLuca J. Objective measurement of cognitive fatigue in multiple sclerosis. Rehabil Psychol. 2004;49:114–22.
Walker LAS, Berard JA, Berrigan LI, Rees LM, Freedman MS. Detecting cognitive fatigue in multiple sclerosis: method matters. J Neurol Sci. 2012;316:86–92.
Holtzer R, Shuman M, Mahoney JR, Lipton R, Verghese J. Cognitive fatigue defined in the context of attention networks. Neuropsychol Dev Cogn. 2011;18:108–28.
Wang C, Ding M, Kluger BM. Change in intraindividual variability over time as a key metric for defining performance-based cognitive fatigability. Brain Cogn. 2014;85:251–8.
Morrow SA, Rosehart H, Johnson AM. Diagnosis and quantification of cognitive fatigue in multiple sclerosis. Cogn Behav Neurol. 2015;28:27–32.
Claros-Salinas D, Dittmer N, Neumann M, et al. Induction of cognitive fatigue in MS patients through cognitive and physical load. Neuropsychol Rehabil. 2013;23:182–201.
Neumann M, Sterr A, Claros-Salinas D, Gütler R, Ulrich R, Dettmers C. Modulation of alertness by sustained cognitive demand in MS as surrogate measure of fatigue and fatigability. J Neurol Sci. 2014;340:178–82.
Berard JA, Fang Z, Walker LAS, et al. Imaging cognitive fatigue in multiple sclerosis: Objective quantification of cerebral blood flow during a task of sustained attention using ASL perfusion fMRI. Brain Imaging Behav. 2019. doi: https://doi.org/10.1007/s11682-019-00192-7.
Cehelyk EK, Harvey DY, Grubb ML, et al. Uncovering the association between fatigue and fatigability in multiple sclerosis using cognitive control. Mult Scler Relat Disord. 2019;27:269–75.
Kluckow SW, Rehbein J, Schwab M, Witte OW, Bublak P. What you get from what you see: parametric assessment of visual processing capacity in multiple sclerosis an its relation to cognitive fatigue. Cortex. 2016;83:167–80.
Hoffman S, Tittgemeyer M, von Cramon DY. Cognitive impairment in multiple sclerosis. Curr Opin Neurol. 2007;20:275–80.
Chinnadurai SA, Venkatesan SA, Shankar G, Samivel B, Ranganathan LN. A study of cognitive fatigue in multiple sclerosis with novel clinical and electrophysiological parameters utilizing the event related potential P300. Mult Scler Relat Disord. 2016;10:1–6.
Hu M, Muhlert N, Robertson N, Winter M. Perceived fatigue and cognitive performance change in multiple sclerosis: uncovering predictors beyond baseline fatigue. Mult Scler Relat Disord. 2019;32:46–53.
Lou JS. Physical and mental fatigue in Parkinson’s disease: epidemiology, pathophysiology and treatment. Drugs Aging. 2009;26:195–208.
Jordan B, Schweden TLK, Mehl T, Menge U, Zierz S. Cognitive fatigue in patients with myasthenia gravis. Muscle Nerve. 2017;56:449–57.
Möller MC, de Boussard NC, Oldenburg C, Bartfai A. An investigation of attention, executive, and psychomotor aspects of cognitive fatigability. J Clin Exp Neuropsychol. 2014;36:716–29.
Berard JA, Smith AM, Walker LAS. Predictive models of cognitive fatigue in multiple sclerosis. Arch Clin Neuropsychol. 2018;17:17.
Aldughmi M, Huisinga J, Lynch SG, Siengsukon CF. The relationship between fatigability and sleep quality in people with multiple sclerosis. Mult Scler J Exp Transl Clin. 2016;2:1–9.
Touzet C. Cognitive fatigue: an impaired cortical inhibitory replenishment. Brain Inj. 2017;31:1625–31.
Wylie GR, Flashman LA. Understanding the interplay between mild traumatic brain injury and cognitive fatigue: models and treatments. Concussion. 2017;2:CNC50.
Chaudhuri A, Behan PO. Fatigue and basal ganglia. J Neurol Sci. 2000;179:34–42.
Chaudhuri A, Behan PO. Fatigue in neurological disorders. Lancet. 2004;363:978–88.
Forwell SJ, Brunham S, Tremlett H, Morrison W, Oger J. Primary and nonprimary fatigue in multiple sclerosis. Int J MS Care. 2008;10:14–20.
Clarke AL, Delano-Wood L, Sorg SF, Werhane ML, Hanson KL, Schiehser DM. Cognitive fatigue is associated with reduced anterior internal capsule integrity in veterans with history of mild to moderate traumatic brain injury. Brain Imaging Behav. 2017;11:1548–54.
Andreasen AK, Iversn P, Marstrand L, Siersma V, Siebner HR, Sellebjerg F. Structural and cognitive correlates of fatigue in progressive multiple sclerosis. Neurol Res. 2019;41:168–76.
Möller MC, Nordin LE, Bartfai A, Julin P, Li T-Q. Fatigue and cognitive fatigability in mild traumatic brain injury are correlated with altered neural activity during vigilance test performance. Front Neurol. 2017;8:1–13.
Stefancin P, Govindarajan ST, Krupp L, Charvet L, Duong TQ. Resting-state functional connectivity networks associated with fatigue in multiple sclerosis with early age onset. Mult Scler Relat Disord. 2019;31:101–5.
Ormstad H, Aass HC, Amthor KF, et al. Serum cytokine and glucose levels as predictors of poststroke fatigue in acute ischemic stroke patients. J Neurol. 2011;258:670–6.
Heesen C, Nawrath L, Reich C, Bauer N, Schulz KH, Gold SM. Fatigue in multiple sclerosis: an example of cytokine mediated sickness behaviour? J Neurol Neurosurg Psychiatry. 2006;77:34–9.
Lou J. Fatigue in Parkinson’s disease and potential interventions. NeuroRehabilitation. 2015;37:25–34.
Dobryakova E, Genova HM, DeLuca J, Wylie GR. The dopamine imbalance hypothesis of fatigue in multiple sclerosis and other neurological disorders. Front Neurol. 2015;6:1–8.
Wang C, Trongnetrpunya A, Samual IBH, Ding M, Kluger BM. Compensatory neural activity in response to cognitive fatigue. J Neurosci. 2016;36:3919–24.
Samuel IBH, Wang C, Burke SE, Kluger BM, Ding M. Compensatory neural responses to cognitive fatigue in young and older adults. Front Neural Circuits. 2019;13:1–12.
Johansson B, Wentzel A-P, Andréll P, et al. Evaluation of dosage, safety and effects of methylphenidate on post-traumatic brain injury symptoms with a focuse on mental fatigue and pain. Brain Inj. 2014;28:304–10.
Mendonça DA, Menezex K, Jog MS. Methylphenidate improves fatigue scores in Parkinson disease: a randomized controlled trial. Mov Disord. 2007;22:2070–6.
Ouellet M-C, Morin CM. Efficacy of cognitive-behavioral therapy for insomnia associated with traumatic brain injury: a single-case experimental design. Arch Phys Med Rehabil. 2007;88:1581–92.
Ulrichsen KM, Kaufmann T, Dørum ES, et al. Clinical utility of mindfulness training in the treatment of fatigue after stroke, traumatic brain injury and multiple sclerosis: a systematic literature review and meta-analysis. Front Psychol. 2016;7:1–11.
Wendebourg MJ, Heesen C, Finlayson M, Meyer B, Pöttgen J, Köpke S. Patient education for people with multiple sclerosis-associated fatigue: a systematic review. PLoS ONE. 2017;12:e0173025.
Ghahari S, Packer T. Effectiveness of online and face-to-face fatigue self-management programmes for adults with neurological conditions. Disabil Rehabil. 2012;34:564–73.
Motl RW, Sandroff BM, DeLuca J. Exercise training and cognitive rehabilitation: a symbiotic approach for rehabilitating walking and cognitive functions in multiple sclerosis? Neurorehabilit Neural Repair. 2015;30:499–511.
Asano M, Finlayson ML. Meta-analysis of three different types of fatigue management interventions for people with multiple sclerosis: exercise, education and medication. Mult Scler Int. 2014;2014:1–12.
Sinclair KL, Ponsford JL, Taffe J, Lockley SW, Rajaratnam SMW. Randomized controlled trial of light therapy for fatigue following traumatic brain injury. Neurorehabil Neural Repair. 2014;28:303–13.
Schoenberger NE, Shif SC, Esty ML, Ochs L, Matheis RJ. Flexyx neurotherapy system in the treatment of traumatic brain injury: an initial evaluation. J Head Trauma Rehabil. 2001;16:260–74.
Cantor JB, Ashman T, Bushnik T, et al. Systematic review of interventions for fatigue after traumatic brain injury: a NIDRR Traumatic Brain Injury Model Systems study. J Head Trauma Rehabil. 2014;29:490–7.
Ruiz ML, Sospedra M, Arce SA, Tejeiro-Martinez J, Benito-León J. Current evidence on the potential therapeutic applications of transcranial magnetic stimulation in multiple sclerosis: a systematic review of the literature. Neurologia. 2018. https://doi.org/10.1016/j.nrl.2018.03.023.
León Ruiz M, Rodríguez Sarasa ML, Sanjuá Rodríguez L, Benito-León J, García-Albea Ristol E, Arce Arce S. Current evidence on transcranial magnetic stimulation and its potential usefulness in post-stroke neurorehabilitation: Opening new doors to the treatment of cerebrovascular disease. Neurologia. 2018;33:459–72.
Sander C, Eling P, Hanken K, Klein J, Kastrup A, Hildebrandt H. The impact of MS-related cognitive fatigue on future brain parenchymal loss and relapse: a 17-month follow-up study. Front Neurol. 2016;7:1–10.
Moher D, Liberati A, Tetzlaff J, Altman DG, Group TP. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA Statement. Open Med. 2009;3:123–30.
Liberati A, Altman DG, Tetzlaff J, et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. PLOS Med. 2009;6:e1000100.
Moher D, Shamseer L, Clarke M, et al. Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement. Syst Rev. 2015;4:1–9.
Stewart LA, Clarke M, Rovers M, et al. Preferred reporting items for a systematic review and meta-analysis of individual participant data: the PRISMA-IPD Statement. J Am Med Assoc. 2015;313:1657–65.
Higgins JPT, Altman DG, Gøtzsche PC, et al. The Cochrane Collaboration’s tool for assessing risk of bias in randomised trials. BMJ. 2011;343:1–9.
Morrow SA, Rosehart H, Johnson AM. The effect of Fampridine-SR on cognitive fatigue in a randomized double-blind crossover trial in patients with MS. Mult Scler Relat Disord. 2017;11:4–9.
Fiene M, Rufener KS, Kuehne M, Matzke M, Heinze H-J, Zaehle T. Electrophysiological and behavioral effects of frontal transcranial direct current stimulation on cognitive fatigue in multiple sclerosis. J Neurol. 2018;265:607–17.
Kurtzke JF. Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology. 1983;33:1444–52.
van Diemen HA, Polman CH, van Dongen TM, et al. The effect of 4-aminopyridine on clinical signs in mutiple sclerosis: a randomized, placebo-controlled, double-blind, cross-over study. Ann Neurol. 1992;32:123–30.
Bever CT Jr, Young D, Anderson PA, et al. The effecst of 4-aminopyridine in multiple sclerosis patients: results of a randomized, placebo-controlled, double-blind, concentration-controlled, crossover trial. Neurology. 1994;44:1054–9.
Schwid SR, Petrie MD, McDermott MP, Tierney DS, Mason DH, Goodman AD. Quantitative assessment of sustained-release 4-aminopyridine for symptomatic treatment of multiple sclerosis. Neurology. 1997;48:(4):817–21.
Stefoski D, Davis FA, Fitzsimmons WE, Luskin SS, Rush J, Parkhurst GW. 4-aminopyridine in multiple sclerosis: prolonged administration. Neurology. 1991;41:1344–8.
Blight AR. Effect of 4-aminopyridine on axonal conduction-block in chronic spinal cord injury. Brain Res Bull. 1989;22:47–52.
Shi R, Kelly TM, Blight AR. Conduction block in acute and chronic spinal cord injury: different dose-response characteristics for reversal by 4-aminopyridine. Exp Neurol. 1997;148:495–501.
Tecchio F, Cancelli A, Cottone C, et al. Brain plasticity effects of neuromodulation against multiple sclerosis fatigue. Front Neurol. 2015;6:141.
Tecchio F, Cancelli A, Cottone C, et al. Multiple sclerosis fatigue relief by bilateral somatosensory cortex neuromodulation. J Neurol. 2014;261:1552–8.
Cancelli A, Cottone C, Giordani A, et al. Personalized, bilateral whole-body somatosensory cortex stimulation to relieve fatigue in multiple sclerosis. Mult Scler J. 2018;24:1366–74.
Ferrucci R, Vergari M, Cogiamanian F, et al. Transcranial direct current stimulation (tDCS) for fatigue in multiple sclerosis. NeuroRehabilitation. 2014;34:121–7.
Schwid SR, Tyler CM, Scheid EA, Weinstein A, Goodman AD, McDermott MP. Cognitive fatigue during a test requiring sustained attention: a pilot study. Mult Scler. 2003;9:503–8.
Goodman AD, Brown TR, Krupp LB, et al. Sustained-release oral fampridine in multiple sclerosis: a raondomized, double-blind, controlled trial. Lancet Neurol. 2009;373:732–8.
Parmenter BA, Denney DR, Lynch SG. The cognitive performance of patients with multiple sclerosis during periods of high and low fatigue. Mult Scler. 2003;9:111–8.
Paul RH, Beatty WW, Schneider R, Blanco CR, Hames KA. Cognitive and physical fatigue in multiple sclerosis: relations between self-report and objective performance. Appl Neuropsychol. 1998;5:143–8.
Ayache SS, Chalah MA. Transcranial direct current stimulation: a glimmer of hope for multiple sclerosis fatigue? J Clin Neurosci. 2018;55:10–2.
Berard JA, Smith AM, Walker LAS. Predictive models of cognitive fatigue in multiple sclerosis. Arch Clin Neuropsychol. 2019;34(1):31–8.
Clancy M, Drerup M, Sullivan AB. Outcomes of cognitive-behavioural treatment for insomnia on insomnia, depression, and fatigue for individuals with multiple sclerosis. Int J MS Care. 2015;17:261–7.
Berard JA, Smith AM, Walker LAS. A longitudinal evaluation of cognitive fatigue on a task of sustained attention in early relapsing-remitting multiple sclerosis. Int J MS Care. 2018;20:55–61.
Bruce JM, Bruce AS, Arnett PA. Response variability is associated with self-reported cognitive fatigue in multiple sclerosis. Neuropsychology. 2010;24:77–83.
Harrison AM, das Nair R, Moss-Morris R. Operationalising cognitive fatigability in multiple sclerosis: a Gordian knot that can be cut? Mult Scler J. 2017;23:1682–96.
Bartolucci AA, Hillegass WB. Overview, strengths, and limitations of systematic reviews and meta-analyses. In: Chiappelli F, et al., editors. Evidence-based practice: toward optimizing clinical outcomes. Berlin: Springer; 2010. p. 17–33.